• Something wrong with this record ?

The markers of the organic acidemias and their ratios in healthy neonates in Serbian population

A. Beletić, A. Tijanić, P. Chrastina, T. Nikolić, A. Stefanović, S. Stanković

. 2022 ; 37 (3) : 271-275. [pub] 20220307

Language English Country Germany

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22025468

OBJECTIVES: The newborn screening (NBS) program in the Republic of Serbia has several decades of tradition, but it has not included any organic acidemias (OA). Therefore, this study aimed to establish the cut-offs of the corresponding NBS markers in the population of healthy newborns. METHODS: In dried blood samples (DBS) collected from 1,771 healthy newborns, we analyzed levels of propionylcarnitine (C3), isovalerylcarnitine (C5), and glutarylcarnitine (C5DC) using tandem mass spectrometry. Further we calculated the following ratios: C3/acetylcarnitine (C3/C2), C3/palmitoylcarnitine (C3/C16), C5/ free carnitine (C0), C5/C2, C5/C3, C5DC/octanoylcarnitine (C8), and C5DC/C0. RESULTS: The cut-offs for methylmalonic acidemia (MMA) or propionic acidemia (PA) were C3>5.73 μmol/L, C3/C2>0.23, and C3/C16>2.36. Based on the study findings, the screening results indicative for isovaleric acidemia (IVA) would include C5>0.372 μmol/L, C5/C0>0.020, C5/C2>0.019, and C5/C3>0.31. Finally, C5DC>0.303 μmol/L, C5DC/C8>7.1, and C5DC/C0>0.019 would justify further testing for glutaric acidemia type I (GA1). The cut-offs were satisfactorily validated via the comparison with worldwide estimates and data for several Caucasian populations. CONCLUSIONS: The levels of the OA biomarkers in the Serbian population of healthy newborns have a distribution pattern similar to the other world populations. Therefore, the proposed cut-offs represent a reliable starting point for the future development of the OA NBS.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025468
003      
CZ-PrNML
005      
20221031100349.0
007      
ta
008      
221017s2022 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1515/dmpt-2021-0218 $2 doi
035    __
$a (PubMed)35254746
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Beletić, Anđelo $u Center for Medical Biochemistry, University Clinical Center of Serbia, Belgrade, Serbia $1 https://orcid.org/0000000189759600
245    14
$a The markers of the organic acidemias and their ratios in healthy neonates in Serbian population / $c A. Beletić, A. Tijanić, P. Chrastina, T. Nikolić, A. Stefanović, S. Stanković
520    9_
$a OBJECTIVES: The newborn screening (NBS) program in the Republic of Serbia has several decades of tradition, but it has not included any organic acidemias (OA). Therefore, this study aimed to establish the cut-offs of the corresponding NBS markers in the population of healthy newborns. METHODS: In dried blood samples (DBS) collected from 1,771 healthy newborns, we analyzed levels of propionylcarnitine (C3), isovalerylcarnitine (C5), and glutarylcarnitine (C5DC) using tandem mass spectrometry. Further we calculated the following ratios: C3/acetylcarnitine (C3/C2), C3/palmitoylcarnitine (C3/C16), C5/ free carnitine (C0), C5/C2, C5/C3, C5DC/octanoylcarnitine (C8), and C5DC/C0. RESULTS: The cut-offs for methylmalonic acidemia (MMA) or propionic acidemia (PA) were C3>5.73 μmol/L, C3/C2>0.23, and C3/C16>2.36. Based on the study findings, the screening results indicative for isovaleric acidemia (IVA) would include C5>0.372 μmol/L, C5/C0>0.020, C5/C2>0.019, and C5/C3>0.31. Finally, C5DC>0.303 μmol/L, C5DC/C8>7.1, and C5DC/C0>0.019 would justify further testing for glutaric acidemia type I (GA1). The cut-offs were satisfactorily validated via the comparison with worldwide estimates and data for several Caucasian populations. CONCLUSIONS: The levels of the OA biomarkers in the Serbian population of healthy newborns have a distribution pattern similar to the other world populations. Therefore, the proposed cut-offs represent a reliable starting point for the future development of the OA NBS.
650    _2
$a vrozené poruchy metabolismu aminokyselin $7 D000592
650    _2
$a biologické markery $7 D015415
650    _2
$a metabolické nemoci mozku $7 D001928
650    _2
$a glutaryl-CoA-dehydrogenasa $x nedostatek $7 D050770
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a isovaleryl-CoA-dehydrogenasa $7 D050769
650    12
$a propionová acidemie $x diagnóza $7 D056693
651    _2
$a Srbsko $7 D055771
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tijanić, Aleksandra $u Center for Medical Biochemistry, University Clinical Center of Serbia, Belgrade, Serbia
700    1_
$a Chrastina, Petr $u Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Nikolić, Tatjana $u Clinic for Gynecology and Obstetrics, University Clinical Centre of Serbia, Belgrade, Serbia
700    1_
$a Stefanović, Aleksandar $u Clinic for Gynecology and Obstetrics, University Clinical Centre of Serbia, Belgrade, Serbia $u School of Medicine, University of Belgrade, Belgrade, Serbia
700    1_
$a Stanković, Sanja $u Center for Medical Biochemistry, University Clinical Center of Serbia, Belgrade, Serbia $u Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
773    0_
$w MED00197248 $t Drug metabolism and personalized therapy $x 2363-8915 $g Roč. 37, č. 3 (2022), s. 271-275
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35254746 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100347 $b ABA008
999    __
$a ok $b bmc $g 1854935 $s 1176758
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 37 $c 3 $d 271-275 $e 20220307 $i 2363-8915 $m Drug metabolism and personalized therapy $n Drug Metab Pers Ther $x MED00197248
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Archiving options